Results 131 to 140 of about 17,963 (297)

Massive prolactinoma with galactorrhoea in a prepubertal boy [PDF]

, 1989
R.J.M. Ross, J M McEniery, Ashley Grossman, I. Doniach, G. M. Besser, Martin O. Savage   +5 more
openalex   +1 more source

Multifunctional Bone Morphogenetic Protein System in Endocrinology [PDF]

, 2013
New biological activities of bone morphogenetic proteins (BMPs) in the endocrine system have recently been revealed. The BMP system is composed of approximately 30 ligands and preferential combinations of type I and type II receptors.
Otsuka, Fumio
core   +1 more source

Long term suppression of prolactin concentrations after bromocriptine induced regression of pituitary prolactinomas. [PDF]

, 1985
K. W. Hancock, J S Scott, J T Lamb, Robert Gibson, C. Chapman   +4 more
openalex   +1 more source

Case Report of a Prolactinoma in a Patient With a Novel MAX Mutation and Bilateral Pheochromocytomas

Journal of the Endocrine Society, 2017
Pheochromocytomas are neuroendocrine tumors that can arise sporadically or be inherited as a familial disease, and they may occur in isolation or as part of a multitumor syndrome. Familial disease typically presents in younger patients with a higher risk
Kelly L. Roszko, Erica Blouch, M. Blake, J. Powers, A. Tischler, R. Hodin, P. Sadow, E. Lawson   +7 more
semanticscholar   +1 more source

Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications. [PDF]

, 2009
peer reviewedaudience: researcher, professionalGermline mutations of the aryl hydrocarbon receptor (AHR)-interacting protein (AIP) gene confer a predisposition to pituitary adenomas (PA), usually in the setting of familial isolated PA. To provide further
Jaffrain-Rea, Marie-Lise, Angelini, M., Gargano, D., Tichomirowa, M. A., Daly, Adrian, Vanbellinghen, Jean-François, D'Innocenzo, E., Barlier, Anne, Giangaspero, F., Esposito, Vincenzina, Ventura, L., Arcella, A., Theodoropoulou, M., Naves, Luciana Ansaneli, Fajardo, C., Zacharieva, S., Rohmer, V., Brue, T., Gulino, A., Cantore, G., Alesse, E., Beckers, Albert   +21 more
core   +1 more source

Case Report of Bilateral Pheochromocytomas due to a Novel Max Mutation in a Patient Known to have a Pituitary Prolactinoma

AACE Clinical Case Reports, 2018
Objective: To report on a patient with a known pituitary prolactinoma also found to have bilateral pheochromocytomas due to a novel germline MAX (MYC-associated factor X) gene mutation. Methods: Case report and literature review.
A. Kobza, Stephanie Dizon, A. Arnaout
semanticscholar   +1 more source

Nerve growth factor and bromocriptine: a sequential therapy for human bromocriptine-resistant prolactinomas [PDF]

, 1995
Cristina Missale, Marco Losa, F. Boroni, Massimo Giovanelli, Andrea Balsari, PierFranco Spano   +5 more
openalex   +1 more source

Prevalence of Autoimmune Thyroiditis and Other Autoimmune Diseases in Relation to Serum BAFF/APRIL Levels in Prolactinoma Patients

Gazi Medical Journal
Objective: There may be an association between hyperprolactinemia and autoimmune diseases, possibly because of the immunostimulatory effect of prolactin.
Özlem Kanburoğlu Meletli, Alev Altınova, Başak Bolayır, Resul Karakuş, Meriç Coşkun, Mehmet Muhittin Yalçın, Müjde Aktürk, İlhan Yetkin, Füsun Saadet Toruner   +8 more
doaj   +1 more source

Chemometric Expertise Of Clinical Monitoring Data Of Prolactinoma Patients

Open Chemistry, 2019
The present investigation indicates hidden relationships between the several clinical parameters usually monitored on prolactinoma patients using non-hierarchical cluster analysis. The major goal of the chemometric data mining is to offer a possible mode
Nedyalkova Miroslava, Dimitrov Dimitar, Donkova Borjana, Simeonov Vasil   +3 more
doaj   +1 more source

Enhanced Slow Wave Sleep in Patients with Prolactinoma [PDF]

, 1998
R.-M. Frieboes
openalex   +1 more source